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TBX1 Is Responsible for Cardiovascular Defects
in Velo-Cardio-Facial/DiGeorge Syndrome
fects can be partially rescued by a human BAC con-
taining the TBX1 gene. Mice heterozygous for a null
mutation in Tbx1 develop conotruncal defects. These
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Boston, Massachusetts 02114 ated efforts to generate deletions in mice in the region
on mouse chromosome 16 (MMU16) that corresponds
to the 1.5 Mb region of HSA22q11 (Figure 1B). Kimber
et al. (1999) generated mice with a 150 kb deletion cov-Summary
ering the proximal part of the 1.5 Mb deleted region.
Mice hemizygous for this deletion were normal. LindsayVelo-cardio-facial syndrome (VCFS)/DiGeorge syn-
drome (DGS) is a human disorder characterized by a et al. (1999) described mice carrying a hemizygous dele-
tion of an estimated 1.2 Mb region from Es2 to Ufd1l onnumber of phenotypic features including cardiovascu-
lar defects. Most VCFS/DGS patients are hemizygous MMU16. This region contains the orthologs of 18 genes
present in the human 1.5 Mb region and one nonortholo-for a 1.5–3.0 Mb region of 22q11. To investigate the
etiology of this disorder, we used a cre-loxP strategy gous gene, Vpreb2. The mutant mice, referred to as
Df1/1 mice, had cardiac outflow tract defects similar toto generate mice that are hemizygous for a 1.5 Mb
deletion corresponding to that on 22q11. These mice those observed in VCFS/DGS patients and some hemi-
zygous mice died soon after birth. These results sug-exhibit significant perinatal lethality and have cono-
truncal and parathyroid defects. The conotruncal de- gested that critical genes for these defects are located
in this region. We recently described mice with a 550
kb deletion from Idd to Arvcf on MMU16 (Puech et al.,11To whom correspondence should be addressed (email: kucherla@
2000) that overlaps significantly with the region deletedaecom.yu.edu or morrow@aecom.yu.edu).
12These three investigators contributed equally to this work. in the Df1/1 mice (Figure 1B). These mice did not exhibit
Cell
620
Figure 1. Map of a Part of Human Chro-
mosome 22q11 (HSA22q11) and Its Corre-
sponding Region on Mouse Chromosome 16
(MMU16)
(A) The relative order of genes on HSA22q11
and the orthologous genes on MMU16 are
shown. Genes are indicated by circles.
Arrows show differences in gene organization
between the two species. Genes localized
between IDD and CTP show the same order
whereas genes localized between RANBP1
and HIRA are inverted in mouse compared
to human. DGCR6 and PRODH are located
proximal to IDD in human but inserted be-
tween Slc20a3 and Ranbp1 in mice. Nonor-
thologous genes are boxed
(B) Mouse models that have been generated
are shown in the lower part of the figure.
conotruncal abnormalities, allowing us to exclude 13 spring from Idd 1/2; Hira 1/2 X 1/1; 1/1 matings. Of
these, 352 (49%) were Idd 1/2 and 352 (49%) weregenes in this region as being solely responsible, when
haploinsufficient, for the outflow tract defects. Hira 1/2. The remaining 11 resulted from recombination
between the Idd and Hira loci and one of them carriedWe now report the generation and characterization
of mice with a hemizygous deletion from Idd to Hira the mutant alleles in cis (cis-Idd/Hira-KO). Cis-Idd/Hira-
KO mice were mated with Zp3-Cre transgenic mice(Lgdel/1 mice), a region containing 24 genes that contains
five more genes than in the Df1/1 mice. We show that (Lewandoski et al., 1997), to introduce the Cre trans-
gene, and mice containing all three modifications werenearly 50% of these mice exhibit conotruncal anomalies
and that the deletion also leads to parathyroid gland mated with C57BL/6 (B6) mice to delete the region from
Idd to Hira (Figure 2B). From 20 such matings, we recov-aplasia and significant perinatal lethality. Attempts to com-
plement the deletion with a duplication of the Idd-Arvcf ered 105 mice, of which 66 (63%) were wild type (WT),
13 (12%) were cis-Idd/Hira-KO, and the remaining 26region and three different BAC transgenes, that together
cover the 1.5 Mb region spanned by the Lgdel, allowed (25%) carried a chromosome with a deletion. Deletion-
carrying mice were identified by a series of PCR reac-us to define a 200 kb region containing four genes,
Wdvcf (Wdr14, Funke et al., 2001), Tbx1 (Chapman et tions (Figure 2C). Of the 26 mice that had a deletion, 14
were mosaic and the remaining 12 were the result ofal., 1996; Chieffo et al., 1997), Gp1bb (Yagi et al., 1994),
and Pnutl (McKie et al., 1997), to be critical for the cono- a germline transmission event. We designated these
deletion heterozygotes Lgdel/1.truncal phenotypes observed in the Lgdel/1 mice. We
generated mice that carry a human BAC containing
these four genes. Embryos heterozygous for the trans- Perinatal Lethality of Lgdel/1 Mice
In the Idd, Hira/11, Zp3-Cre/1 X WT crosses describedgene exhibit cardiovascular abnormalities. We also ex-
amined the expression patterns of these four genes and above, we noted that 25% of Lgdel/1 mice, 14% of the
mosaic Lgdel/1 mice, and 8% of Idd, Hira/11 micefound that one of them, Tbx1, is expressed in the pharyn-
geal arches. Based on these data, Tbx1 can be consid- died after birth compared to less than 2% of similar
deaths among WT siblings. Examination of offspringered a candidate for some of the phenotypes in VCFS/
DGS patients. To test this feature, we generated mice from Lgdel/1 X WT matings confirmed the perinatal
lethality of Lgdel/1 mice. Genotyping of 256 mice fromwith a null mutation in the Tbx1 gene. Mice heterozygous
for this mutation developed cardiovascular defects. 48 litters revealed that 184 (72%) of them were WT and
72 (28%) were Lgdel/1. To assess the stage of lethalityThese results provide strong evidence that haploinsuffi-
ciency of TBX1 is responsible for the cardiovascular of Lgdel/1 mice, we examined the genotypes of em-
bryos at 10.5, 11.5, 12.5, and 18.5 days of embryogene-defects seen in VCFS/DGS patients.
sis. Lgdel/1 embryos were recovered in the expected
Mendelian ratio from all stages of embryogenesis exam-Results
ined, suggesting that a significant percentage of the
Lgdel/1 mice died at or shortly after birth. We foundTargeted In Vivo Deletion of the Chromosomal
Region between Idd and Hira in Mice that several newborns die during the first day of life.
To generate mice with a targeted deletion of the chromo-
somal region from Idd to Hira (Figure 1), we bred mice Phenotypic Analysis of the Lgdel/1 Mice
Cardiovascular Defects in Lgdel/1 Embryosthat were homozygous for the Idd mutant allele (Puech
et al., 2000) with mice heterozygous for the Hira mutant Cardiac defects are observed in z80% of VCFS/DGS
patients (Shprintzen et al., 1985; Van Mierop and Kutsche,allele (A. W.-B. and P. S., unpublished data). Both the
Idd and the Hira mutant alleles included insertions con- 1986; Goldberg et al., 1993; Ryan et al., 1997) and were
detected in Df1/1 mice (Lindsay et al., 1999). We exam-taining loxP sites in the same orientation (Figure 2A).
To obtain mice that have the two mutant alleles on ined embryos from 18.5 day pregnant B6 females that
were mated with Lgdel/1 males. A total of 156 embryosthe same chromosome in cis, we genotyped 715 off-
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from 20 litters were analyzed. 80 embryos (51%) were
hemizygous for the deletion and 76 (49%) were WT. The
heart appeared normal in size and shape in all mice
(data not shown). To identify vascular patterning defects,
corrosion casts were prepared by injecting red and blue
methylmethacrylate into the left and right ventricles, re-
spectively. After hardening, the soft tissues were dissolved
leaving a mold of the vasculature (see Experimental Pro-
cedures). Representative results are shown in Figure 3.
We found that 47% of the Lgdel/1 embryos had abnor-
mal patterning of the great vessels, while all of the wild-
type littermates were normal (Figure 3A).
Twelve of the 80 Lgdel/1 embryos examined (15%)
had defects that would be considered critical or lethal
in human infants. These included 4 cases (5%) of a right-
sided aortic arch with a left-sided ductus arteriosus (Fig-
ure 3B). In these cases, the aortic arch was posterior to
the esophagus and trachea (not shown) such that a
vascular ring capable of causing compression of the
trachea was present. The left common carotid artery
arose ectopically from the proximal ascending aorta.
We observed 8 cases (10%) of complete interruption of
the aortic arch, which were always of the type B variety,
i.e., the interruptions occurred between the left carotid
artery and the left subclavian artery (Figure 3C). In cases
of complete interruption of the aortic arch, blood supply
to the descending aorta is provided by flow through
the patent ductus arteriosus. At birth, when the ductus
closes, concomitant with increased oxygen tension,
blood supply to the descending aorta would be compro-
mised and neonatal lethality would be expected. These
severe vascular defects account for at least some of the
perinatal lethality observed in Lgdel/1 newborn mice.
Less severe vascular anomalies were also detected
in Lgdel/1 embryos. The right subclavian artery arose
ectopically in many cases. In 5 of 80 (6%) heterozygous
embryos examined, the right subclavian arose from the
ascending aorta instead of arising as a branch of the
innominate artery (data not shown). This is considered
a normal variant in humans, but we never observed this
anomaly in the wild-type murine embryos examined. In
13 cases (16%), the right subclavian artery arose from
the distal portion of the aortic arch and traveled posteri-
orly to the right foreleg indicating a retroesophageal
Figure 2. Strategy to Generate an In Vivo Deletion from Idd to Hira subclavian artery (Figures 3D and 3E). In 7 cases (9%),
(A) Schematic representation of the Idd and Hira targeting con- the innominate artery was unusually long (more than
structs. The exons of both genes are shown as white boxes. The twice normal) prior to the origin of the subclavian artery
PGK Neo cassettes and a solitary PGK promoter (P) are represented (Figure 3F). These defects would not be expected to
by black boxes and the loxP sites by black triangles. PCR primers cause significant morbidity or mortality.
used for genotyping and detection of the gene-targeting events are
We examined four E13.5 embryos for cardiac anoma-indicated by arrows.
lies. We found that in one case, there was a ventricular(B) Steps involved in generating an in vivo deletion from Idd to Hira.
septal defect (VSD) and associated thin myocardium.Briefly, mice containing mutant alleles of Idd and Hira in trans were
mated with C57BL/6 mice. The offspring are screened by PCR for Evidence for VSD was also noted in some Lgdel/1 E18.5
a meiotic recombination event between the Idd and Hira loci and embryos when methylmethacrilate was observed to
the identified cis-Idd/Hira-KO mice were mated with ZP3-Cre mice quickly and easily cross the ventricular septum. VSD
to enter the Cre transgene. To delete the region comprised within was reported as a feature in VCFS/DGS patients.
the two loxP sites (black triangles), mice containing all three modifi-
The cardiac and vascular defects that we observedcations were then crossed with C57BL/6 mice. A deletion event can
are similar to those reported in VCFS/DGS patients andbe detected by PCR using the primers for PGK1 and Neo5F as
can all be related to defects in persistence or regressionindicated by the black arrows (see also Figure 2C).
(C) Genotyping by PCR analysis. Mice containing the Lgdel chromo- of aortic arches 3, 4, and 6. Neural crest cells populate
some, a duplication from Idd to Arvcf, or mice with a Idd/Hira-cisKO these aortic arches during development, a process that
targeted chromosome can be easily distinguished from wild-type is critical for regulation of the remodeling process. Simi-
mice by PCR. The primer pairs used are indicated on the right side lar vascular defects have been observed after ablation
of the Figure (see also Experimental Procedures).
of neural crest in chick embryos (Kirby et al., 1983).
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Figure 3. Cardiovascular and Parathyroid Abnormalities in Lgdel/1 E18.5 Embryos
Corrosion casts were prepared (see Experimental Procedures) from wild-type and Lgdel/1 E18.5 embryos by injection of blue acrylic into the
right ventricle and red acrylic into the left ventricle.
(A) Normal anatomy in a wild-type embryo. The ascending aorta gives rise to the innominate artery (IA) that bifurcates into right subclavian
artery (RSA) and right common carotid (RCC). The next arteries branching from the aortic arch (AA) are left common carotid (LCC) and left
subclavian artery (LSA). (DAo 5 descending aorta.)
(B) Right-sided aortic arch with a left-sided ductus arteriosus.
(C) Interrupted aortic arch of the type B variety (IAA-B).
(D and E) Retro-esophageal subclavian artery. The RSA arises from the distal portion of the aortic arch and travels along a posterior route to
the right arm.
(F) The innominate artery is more than twice as long as normal and arises prior to the origin of the subclavian artery.
AA 5 aortic arch; IA 5 innominate artery; RCC/LCC, right/left common carotid arteries; RSA/LSA 5 right/left subclavian arteries.
(G and H) Cross sections of thyroid and parathyroid from WT(G) and Lgdel/1 (H) mice stained with H&E. The absence of parathyroid was
determined by examining more than 150 consecutive serial sections from each mouse.
These results suggest that haploinsufficiency of func- roid glands (Goldberg et al., 1993; Ryan et al., 1997;
Scuccimarri and Rodd, 1998). A deficit in thymic functiontions encoded by the region of mouse chromosome 16
between Idd and Hira regulate neural crest patterning can result in a deficiency of T cells and can be demon-
strated by measuring the proportion of CD41 lympho-of the aortic arches.
Phenotypic Analysis of the Thymus, Thyroid, cytes. To determine whether these features are also
present in the Lgdel/1 mice, we analyzed E18.5 embryosand Parathyroid Glands in Lgdel/1 Mice
In addition to conotruncal defects, VCFS/DGS patients for thymic hypo- or aplasia as well as T cell immune
defects. All of the 24 embryos (7 Lgdel/1 embryos andshow absence or hypoplasia of the thymus and parathy-
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17 WT embryos) analyzed had an intact and normal three BACs. Transgenics that retained the intact BAC
were used for further study. Studies of expression pat-sized thymus. Flow cytometry analysis of the T cell pop-
ulations in the thymus was performed using CD3, CD4, terns of the transgenes revealed that all of them were
expressed in the same spatio-temporal pattern as theirand CD8 markers and no significant differences were
found in Lgdel/1 mice compared to their WT littermates mouse counterparts (results not shown). Transgenics
from BACs 467 and 339 did not have any discernable(data not shown).
Rhombencephalic neural crest cells together with the phenotypes. We observed that two lines of transgenics
from BAC316, 316.23, and 316.27 had abnormal ratiosendoderm of the primitive pharynx give rise to the thy-
roid, parathyroid, and thymus glands (Le Douarin, 1981). of WT:Tg mice, 63:37 (n5428) and 61:39 (n5193) re-
spectively indicating significant neonatal lethality ofIn histological sections, the thyroid gland is located ad-
jacent to the rostral larynx. The parathyroid glands are transgenic mice. To ascertain if this lethality is due to
cardiovascular defects, we examined the cardiovascularembedded within the posterolateral regions of the thy-
roid gland. We examined a total of 13 newborns for system of E18.5 embryos by the corrosion cast tech-
nique. We examined 26 transgenic embryos and 37 WTdefects in the thyroid and parathyroid glands. Out of 13
mice analyzed, 6 were WT and 7 were Lgdel/1 mice. The littermates. Representative results are shown in Figure 4.
Fourteen of 26 (54%) 316.23 transgenic embryos hadthyroid gland was normal in size and shape in all mice. In
contrast, while the size and shape of the parathyroid vascular defects involving the aortic arch and/or great
vessels. Five embryos had retroesophageal subclavianglands were normal in all WT mice, 5 of 7 Lgdel/1
mice had no detectable parathyroid glands (Figures 3G arteries (Figure 4B). Three embryos had pulmonary atre-
sia (Figure 4C). In these embryos, the pulmonary vascu-and 3H).
lature filled retrograde via the patent ductus arteriosus.
In these embryos, a ventricular septal defect was pres-Definition of the Critical Region
ent. Five embryos displayed a persistent right-sided aor-for Conotruncal Defects
tic arch. In these embryos, the left carotid artery wasThe Idd-Hira region in the mouse genome encompasses
the first major branch of the ascending aorta instead ofan estimated 1.5 Mb region and contains 24 genes. Our
the innominate artery (e.g., Figure 4D). A left-sided duc-earlier studies showed that a deletion of the 550 kb Idd-
tus arteriosus was present. Since the right-sided aorticArvcf region did not lead to neonatal lethality in the
arch travels posterior to the esophagus and trachea, ahemizygous state nor did the mice exhibit any physical
vascular ring was present with the potential for com-malformations including conotruncal defects at 18.5
pressing these structures. In one case (Figure 4D), pul-days of embryogenesis (Puech et al., 2000). To confirm
monary atresia and a right-sided aortic arch were pres-these observations and to better define the localization
ent in the same embryo. In this case, the ductusof the gene responsible for the phenotypes, we per-
arteriosus anastomosed with the left subclavian arteryformed intercrosses of Lgdel/1 mice with a line that
instead of the descending aorta and served to fill thecarried a duplication of the 550 kb region spanning Idd
pulmonary vasculature. One newborn transgenic animalto Arvcf designated Dup (Puech et al., 2000).
also had an interrupted aortic arch, type B (not shown).We examined 141 mice from matings between Lgdel/1
An E18.5 embryo had a complex outflow tract malforma-mice and Dup Idd-Arvcf mice. Complementation of neo-
tion and a ventricular septal defect (Figure 4E). All ofnatal lethality observed in Lgdel/1 mice would lead to
these defects are related to inappropriate persistencean equal proportion of mice carrying the deleted and
or regression of aortic arch arteries three, four, and six.the duplicated chromosome (Dup/Lgdel) and those that
Migrating cardiac neural crest cells populate these threeare Dup/1. Of the adult 141 mice examined, 97 (69%)
aortic arches. Therefore, the phenotypes observed arewere Dup/1 while 44 (31%) were Dup/Lgdel. Seven of
likely due to abnormalities in this aspect of development.51 (14%) Lgdel/Dup mice died soon after birth, com-
No vascular defects were observed in any of the wild-pared to only 1% (1/98) of their Dup/1 littermates. These
type embryos examined. These results suggested thatresults confirmed our earlier finding that the region from
one or more of the genes on BAC316 are dosage sensi-Idd to Arvcf is not responsible for the lethality phenotype
tive and an increased level of expression of this gene(s)observed in Lgdel/1 mice. These results also suggest
causes cardiovascular anomalies.that functional hemizygosity of the region Arvcf-Hira,
carrying ten genes, is sufficient to lead to neonatal le-
thality. Thymus Hypoplasia and Maldescent
in BAC Transgenic Mice
Incomplete migration of the thymus tissue from the phar-BAC Transgenic Mice
To further narrow the region harboring the gene(s) re- ynx into the mediastinum was detected with variable
severity in BAC316.23 transgenic mice (n 5 9; Figuressponsible for conotruncal heart defects and perinatal
mortality, we generated three strains of transgenic mice 4F and 4G). Specifically, the two mediastinal lobes of
the thymus were smaller in size and the superior borderscontaining human BACs encompassing the region from
ARVCF to NLVCF (Figure 1B). Human BACs were chosen extended as long slender strands into the neck 7–9 mm
above the clavicles (n 5 6; Figure 4G). Occasionally,to unambiguously ascertain the expression pattern of
the transgenes. BAC467 contained three genes, ARVCF, there were small ectopic lobules at the cranial ends of
these strands, which was confirmed by FACS analysisCOMT, and TRXR2. BAC316 contained four genes,
WDVCF, TBX1, GP1Bb , and PNUTL. BAC339 contained of this tissue. Fluorescence-activated cell sorting (FACS)
was performed using thymocytes from the 316.23.FVBfour genes, TMVCF, CDC45L, UFD1L, and NLVCF. We
generated several founders from injection of each of the line. All thymocyte subpopulations, CD41, CD81, CD31,
Cell
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Figure 4. Cardiovascular and Thymus Defects in 316.23 Transgenic Mice
Examples of corrosion casts in E18.5 wild-type (A) and transgenic littermates (B–D). The left ventricle was injected with red methylmethacrylate
and the right ventricle was injected with blue methylmethacrylate. The patent ductus arteriosus (DA) prior to birth allows mixing of red and
blue. The venous system has been removed.
(A) Wild-type embryo. The ascending aorta (Ao) gives rise to the braciocephalic artery that quickly bifurcates into the right subclavian artery
(RSA) and the right carotid artery (RCC). The next branch is the left carotid artery (LCC) followed by the left subclavian artery (LSA). The
proximal pulmonary artery (PA) gives rise to the right and left pulmonary arteries (RPA, LPA) and the ductus arteriosus that joins the descending
aorta.
(B) Transgenic embryo with a retroesophageal right subclavian artery (arrows) that originates from the descending aorta and travels posteriorly.
(C) Transgenic embryo with pulmonary atresia. The RPA and LPA fill retrograde through the DA with red methylmethacrylate. No proximal
pulmonary artery is present. (Location where the proximal PA should be seen is marked with arrowhead).
(D) Transgenic embryo with a right aortic arch and pulmonary atresia. The first branch of the ascending aorta is the LCC, followed by the
RCC and RSA. No brachiocephalic artery is seen. The aortic arch travels posteriorly. The RPA and LPA fill retrograde via the DA, which
branches from the LSA (arrowhead) instead of from the descending aorta. This embryo represents a variant of a congenital “vascular ring”
defect seen in some human infants.
(E) H&E stained cross section through the heart of an E18.5 transgenic embryo reveals a ventricular septal defect (VSD) connecting the left
ventricle (LV) and right ventricle (RV).
(F and G) Representative thymi from normal (E) and transgenic littermates (F) within the body cavity of six-week-old mice.
and CD4-/CD82, were present in normal ratios but were showing that, in contrast to thymus development, over-
expression of the transgenes did not affect parathyroidreduced in number in the transgenic mice compared
to wild-type littermates, consistent with their smaller development or function.
thymus size (data not shown). No obvious defects were
found in the parathyroid glands of eight 316.23 transgenic Complementation of the Phenotypes in Lgdel/1
Mice by BAC Transgenicsand three wild-type littermates. Consistent with this find-
ing, circulating parathyroid hormone levels in these trans- To ascertain if the gene(s) on BAC316 is also responsible
for the cardiovascular defects seen in VCFS/DGS pa-genics were also in the normal range (60.3 1/2 11.6)
Important Role for TBX1 in VCFS/DGS
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Figure 5. Expression Pattern of Tbx1 in E10.5
Mouse Embryos
(A) Cross section of E10.5 embryo at the level
of the cardiac outflow tract reveals mesen-
chymal expression of Tbx1 surrounding the
third aortic arch artery (3), the dorsal aorta
(DA), and the cardinal vein (CV).
(B) Sagittal section of E10.5 embryo through
the pharyngeal arches reveals Tbx1 expres-
sion surrounding the aortic arch arteries
(numbered 2,3,4), especially around aortic
arch artery 4. Br, brain; Ht, heart; NT, neural
tube. Sense probe yielded no signal (not
shown).
tients, we mated the 316.23 mice with the Lgdel/1 mice. gested that TBX1 has an important role in the cardiovas-
cular defects observed in VCFS/DGS patients.Similar crosses were also made with the two other BAC
transgenics.
We analyzed 120 mice from a mating of Lgdel/1 mice Mice with a Mutation in Tbx1
To definitively assess the role of Tbx1 in the phenotypesand mice heterozygous for the TMVCF-NLVCF BAC
transgenes. This mating should yield four classes of observed in Lgdel/1 mice, we generated mice that carry
a mutation in this gene. The gene targeting constructmice, two of which carry the Lgdel chromosome. Among
the offspring of this mating, mice carrying the Lgdel used for this purpose is shown in Figure 6A. Correct
gene targeting was verified by Southern blot analysischromosome were underrepresented (38%). Among the
45 mice carrying the Lgdel chromosome, 20 contained (Figure 6B). Embryonic stem (ES) cells carrying the modi-
fied locus were injected into B6 embryos and severalthe transgene while the rest did not. Similar results were
obtained in crosses between Lgdel/1 mice and ARVCF- chimeric mice were generated. The highly chimeric
mice from two independently derived ES cell lines wereTRXR2 BAC transgenic mice. These results suggest that
the genes responsible for the neonatal lethality may lie mated with B6 females and 18.5 day embryos were geno-
typed and examined for conotruncal defects. Fourteenin the Wdvcf-Pnutl region. The 316 BAC transgenic mice,
containing different numbers of transgene copies, ex- Tbx11/2 embryos and 14 wild-type littermates were
examined. We observed that 7/14 (50%) of the Tbx11/2hibited a number of phenotypes that are similar to those
observed in VCFS/DGS patients including conotruncal embryos had abnormalities of patterning of the great
vessels including two that had an abnormal origin ofdefects. Therefore, we examined the ability of the 1-2
copy line to complement the conotruncal defects seen the right subclavian artery (RSA, Figure 7A), two with
retroesophageal RSA (Figure 7B), one with an inter-in Lgdel/1 mice. From several matings of Lgdel/1 X
Tg316/1 mice, we examined a total of 82 embryos. All rupted aortic arch and a retroesophageal RSA (Figure
7C), one with an RSA that arose from the pulmonaryof the 1/1 and Tg316/1 embryos were normal. While
50% of the Lgdel/1 embryos had some sort of conotrun- artery instead of from the systemic vasculature (Figure
7D), and one with an abnormally high aortic arch (“cervi-cal defect, only 14% of the Lgdel/1, Tg316/1 mice had
vascular anomalies. These results suggested that the cal arch”, not shown). The majority of these haploinsuffi-
cient phenotypes would be compatible with postnataltransgene is capable of partially rescuing the vascular
defects observed in Lgdel/1 embryos. survival. No vascular defects were seen in the wild-type
embryos examined. These observations clearly show
that reduced dosage of Tbx1 results in conotruncal de-Expression Pattern of Tbx1 Gene
We examined the expression patterns of the four genes fects in mice.
on BAC316. Since VCFS/DGS is the result of develop-
mental defects, we determined the sites of expression Discussion
of the four genes by in situ hybridization of histological
sections and by whole mount hybridization of E9.5–11.5 VCFS/DGS is a common developmental disorder that
results from haploinsufficiency of a part of human chro-embryos. No signals were detected for Wdvcf and
Gp1bb in these embryos and Pnutl was expressed in mosome 22. Among the most common phenotypes
found in VCFS/DGS patients are cardiovascular anoma-the developing nervous tissue (results not shown). In
contrast, Tbx1 was expressed in the core mesenchyme lies. Since many of the organ systems affected in VCFS/
DGS patients are of neural crest origin, the syndromeof the pharyngeal arches surrounding the aortic arch
arteries, the mesenchyme near the paired dorsal aortae is considered a developmental disorder resulting from
deficiency or improper migration of neural crest cells.to the pharynx and the cells surrounding the aortic arch
arteries (Figure 5). Taken together, these results sug- To understand the genetic etiology and to generate a
Cell
626
Figure 6. Strategy to Generate a Null Muta-
tion in the Mouse Tbx1 Gene
Hygro refers to a selection cassette con-
taining PGK-Hygro and pNeo.
mouse model of VCFS/DGS, we generated mice carrying also showed that a large proportion of the Lgdel/1 mice
had parathyroid abnormalities. Both cardiac and para-two deletions. One of them is designated Lgdel and
encompasses a 1.5 Mb region (this report). The other thyroid phenotypes can be explained by an alteration
in the fate of cardiac neural crest cells during em-deletion designated Idd-Arvcf deletion covers a 550 kb
region (Puech et al., 2000). bryogenesis. During gestation, pairs of branchial arch
arteries form and all of the caudal arch arteries developWe observed that the Lgdel/1 mice have three fea-
tures of VCFS/DGS patients. First, there is a significant symmetrically until around E11.5. They then undergo
dramatic remodeling to establish the embryonic asym-perinatal lethality among the Lgdel/1 mice. Most cases
of DGS are incompatible with life (DiGeorge, 1965; Finley metric circulatory system. This remodeling process in-
cludes the asymmetrically programmed regression andet al., 1977; Conley et al., 1979). Careful observation of
the number of newborn pups in each mating and the persistence of specific arch arteries (for reviews see
Creazzo et al., 1998; Sucov, 1998; Epstein and Buck,number that remain after one day suggests that most,
if not all, of the lethality occurs during the first day after 2000). Aortic arch remodeling requires the presence of
cardiac neural crest cells. The cardiovascular pheno-birth. Some of the newborns were cyanotic, suggesting
that death could be related to cardiovascular disorders. types described in the Lgdel/1 embryos can be ex-
plained by a failure of remodeling of the fourth and sixthSimilar to most human VCFS/DGS patients, a significant
fraction of Lgdel/1 mice have cardiac conotruncal de- arch arteries. Likewise, portions of the parathyroid gland
are derived from the cranial neural crest. In summary,fects. Parathyroid abnormalities, another common fea-
ture of VCFS/DGS, were also observed in Lgdel/1 mice. our results indicate that monosomy for the region from
Idd to Hira impairs normal development of several struc-Based on these results, Lgdel/1 mice can serve as a good
model for at least some of the features of VCFS/DGS. tures derived from the neural crest, the parathyroid/
heart, and great vessels emerging from the heart.Four different deletions covering portions of mouse
chromosome 16 homologous to HSA22q11 have now To identify the critical region harboring the gene(s)
responsible for the conotruncal defects observed in thebeen described (Kimber et al., 1999; Lindsay et al., 1999;
Puech et al., 2000; and this report). The largest of these Lgdel/1 mice, we attempted to complement this dele-
tion by breeding Lgdel/1 mice with mice carrying ais the Idd-Hira deletion described here and the second
largest is the deletion of the Dgs-i-Ufd1l region (Df1) duplication of the region from Idd to Arvcf and with mice
containing BAC transgenes of the region from TMVCF(Lindsay et al., 1999). Df1/1 mice show perinatal lethality
although with a lower frequency than that observed in to NLVCF (Figure 1B). We showed that neither the dupli-
cation of the region from Idd to Arvcf nor additionalLgdel/1 mice. Since five more genes are hemizygous
in the Lgdel/1 mice, it is possible that the increased copies of the region from TMVCF to NLVCF or from
TRXR2 to ARVCF can partially rescue the phenotypelethality is the result of the deletion of these additional
genes. The other two smaller deletions did not cause observed in the Lgdel/1 mice. These results indicate
that the gene(s) responsible for cardiac outflow defectsperinatal lethality in the hemizygous state (Kimber et al.,
1999; Puech et al., 2000). Taken together, these results and neonatal lethality is located in a region of about 200
kb containing four known genes, WDVCF, TBX1, GP1Bb,suggest that haploinsufficiency of the region from Arvcf-
Ufd1l is sufficient to result in perinatal lethality. and PNUTL. This view was substantiated by the obser-
vation that a substantial proportion of transgenic miceWe observed that 47% of E18.5 Lgdel/1 embryos
had cardiovascular defects (Figures 3B–3F). Most of the containing the BAC with these four genes die soon after
birth and cardiac and conotruncal defects can be de-vascular anomalies seen in the Lgdel/1 embryos have
also been observed in VCFS/DGS patients (Shprintzen tected. Previously, mice with a mutation in Gp1bb have
been described. They were shown to mimic a humanet al., 1985; Goldberg et al., 1993; Ryan et al., 1997). We
Important Role for TBX1 in VCFS/DGS
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Figure 7. Conotruncal Defects in Tbx1 1/2 Mouse Embryos
(A) Abnormal origin of the right subclavian artery (RSA) is noted in this embryo (arrowhead). Note the unusually distal bifurcation of the right
innominate artery into the RSA and the right common carotid artery (RCC) and the medial direction of the proximal RSA. AAo 5 ascending
aorta.
(B) Retroesophageal RSA is evident (arrowheads). The RSA arises from the descending aorta just distal to the origin of the left subclavian
artery (LSA) and travels posteriorly to the right forelimb.
(C) Complete interruption of the aortic arch with retroesophageal RSA is evident in this embryo in which the right ventricle injection only is
shown. The main pulmonary artery (PA) is indicated giving rise to the right and left pulmonary arteries (RPA and LPA) and to the ductus
arteriosus (DA). This injection fills the descending aorta as well as the subclavian arteries. The RSA arises from the descending aorta and
travels posteriorly (arrowheads). The aortic arch is not filled by this injection. The proximal ascending aorta arising from the left ventricle gave
rise to the carotid arteries (not shown). Mixing of blue and red colors in this cast indicates the presence of a ventricular septal defect.
(D) Right posterior oblique view reveals the origin of the RSA from the proximal PA at the point where the PA bifurcates into RPA and LPA.
Normally, the RSA arises from the right innominate artery, which bifurcates in to RCC and RSA. LCC is left common carotid. AAo is ascending
aorta.
autosomal recessive bleeding disorder Bernard-Soulier early embryogenesis in the pharyngeal arches, pouches,
and otic vesicle (Chapman et al., 1996; Chieffo et al.,syndrome. This syndrome bears no resemblance to
VCFS/DGS (Ware et al., 2000). Of the three remaining 1997). The Tbx genes are a family of dosage-sensitive
genes and two of its members have been associatedgenes, Wdvcf is a WD40 repeat containing gene that is
ubiquitously expressed at low levels in a variety of hu- with dominant human disorders. Mutations in TBX5 re-
sult in Holt-Oram syndrome that is associated with heartman and mouse adult and fetal tissues (Funke et al.,
2001). The Pnutl gene also referred to as Cdcrel-1 is defects (Basson et al., 1997; Li et al., 1997; Basson et al.,
1999). Tbx3 mutations cause mammary-ulnar syndromeexpressed predominantly in the nervous system (Maldo-
nado-Saldivia et al., 2000) and is suggested to be in- (Bamshad et al., 1997).
To test the involvement of TBX1 in the phenotypesvolved in the regulation of synaptic vesicle function
(Beites et al., 1999). It is not expressed in the pharyngeal associated with VCFS/DGS, we generated mice with a
null mutation in this gene. Mice that are hemizygousarches or outflow tract of the heart, suggesting that
this gene may not be responsible for the conotruncal for the Tbx1 mutation had cardiovascular phenotypes
similar to those in the Lgdel/1 mice and in VCFS/DGSanomalies in the Lgdel/1 mice. Tbx1 is a member of a
phylogenetically conserved family of genes that share patients. These results clearly show that TBX1 plays a
critical developmental role in the formation of at leasta common DNA binding domain, termed the T box. T
box genes are transcription factors involved in the regu- some of the organ systems derived from neural crest
including the cardiovascular system.lation of developmental processes. Tbx1 is expressed
across a wide range of embryonic stages from blasto- It has to be noted that neither the Tbx1 mutant hetero-
zygotes nor the Lgdel/1 mice have all of the phenotypescyst through gastrulation and early organogenesis
(Chapman et al., 1996). Mouse Tbx1 is expressed during observed in VCFS/DGS patients. The involvement of
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BACSP6-F (GCTGCAGATCCCTAAACAGC) and BAC probe-R (AGCother linked or unlinked genes in the manifestation of all
GCTATATGCGTTGATGC) were used to generate a PCR productof the phenotypes seen in VCFS/DGS patients requires
from the SP6 end of the same vector that was also used as a probeadditional investigation.
for genomic Southern analysis (see below). FVB or C57B1/6 mice
were used to establish colonies from the founder animals.
Experimental Procedures
Analysis of Embryos and MiceGeneration of Idd and Hira Heterozygous Mice
Mice were kept on a 12 hr light/dark cycle and noon of the plugTwo separate targeting vectors for the Idd and the Hira locus were
date was considered as 0.5 d.p.c. DNA for genotyping was preparedconstructed to generate an in vivo deletion of the chromosomal
from tail using the DNeasy Tissue Kit from Qiagen and following theregion between Idd and Hira in mice.
instructions of the manufacturer.In one, the Idd locus was disrupted by homologous recombination
resulting in the deletion of a 2 kb segment including Idd exons 4
Genotyping by PCRand 5 (Puech et al., 2000; Figure 2A) and in the second, the Hira
The following primers were used for genotyping of the mice andlocus was disrupted by deleting a 1.5 kb region including the 39 part
embryos:of exon 8 (A. W.-B. and P. S., unpublished data; Figure 2A).
PGK1, GCTAAAGCGCATGCTCCAGAC; Neo5F, ACCGCTATCAGA PGKNeo cassette and a loxP site in the same orientation have
GACATAGCGT;also been included in both targeting vectors. The vectors were trans-
Idd-KO1, CTGTTGTTGACACAGCACATG; 6x32t3, AACTCTACCTfected separately into embryonic stem (ES) cells and ES cell clones
GTTCCTACTG;bearing the mutant alleles were used to generate chimeric mice.
Idd-KO2, CACGTTGTCATTCTCAGACATG; HiraR1, GTGATGCHeterozygous offspring for both mutant alleles were generated by
TAGTCTCTAGCTG;further crossing the chimeric founders with B6 females.
HiraF1, TCTTGCAACTCTGAGAGGTC; CreF, GGACATGTTCAGG
GATCGCCAGGCG; CreR, GCATAACCAGTGAAACAGCATTGCTG.Tbx1 Gene Targeting
The primers were combined as follows (Figure 2C): Idd-KO2/Neo5FThe genomic sequence of Tbx1 (GenBank Accession number
or Idd-KO1/PGK1 for identification of a homologous recombinationAC003066) was used to generate an exon/intron and restriction
event at the Idd locus, Idd-KO1/6x32t3 for amplification of the Iddenzyme map. A 13 kb SpeI-EcoRV fragment from BAC 213A6 (RPCI
wild-type allele, HiraF1/Neo5F for identification of a homologous21; http://www.chori.org/bacpac/) containing Tbx1 exon 1 through
recombination event at the Hira locus, and HiraF1/HiraR1 for amplifi-part of exon 6 was subcloned into pZErO-2 (Invitrogen). The plasmid
was digested with AatII and NruI to release a 4.9 kb Tbx1 genomic cation of the Hira wild-type allele. To amplify the junction fragment
fragment including exons 1 and 2 (exon 2 contained the ATG). This of the Idd and Hira target vectors after a deletion event, the primers
interval was blunt-ended and replaced with a hygromycin resistance PGK1/Neo5F were used. Cre-F/Cre-R primers were used for amplifi-
cassette. To generate the targeted embryonic stem (ES) cell clones, cation of the Cre transgene. 7 ul of DNA was used as a template in
30 ug of linearized targeting vector was electroporated into 2.5 3 the PCR reaction. The PCR conditions were 948C for 4 min, one
107 WW6 ES cells and selected for hygromycin resistance. Colonies cycle; 588C for 45 s, 728C for 45 s, and 948C for 30 s (35 cycles);
were picked after ten days and their DNA was screened by PCR 728C for 1 min, one cycle.
using the forward primer from the hygromycin cassette, 59-AGGTCC
CTCGAAGAGGTTCA-39 and reverse primer from exon 6, 59-GTC Corrosion Casts
CACATAGACAACATGGAA-39. The reaction was performed using Embryos were isolated of 18.5 days pregnant B6 females insemi-
the Expand Long Template PCR System for amplification of a 3.2 nated by Lgdel/1 males and the heart exposed by a thoracic incision
kb product (Buffer 3; Roche Pharmaceuticals). Chimeric mice were and rib removal. Batson no. 17 acrylic (Polysciences, Inc) was in-
generated by injecting C57Bl/6 blastocysts with 8–12 ES cells de- jected into the right and left ventricle until the entire embryonic
rived from clone 7D6 or 1C3. Both lines gave rise to male chimeric vasculature was filled. After hardening, the tissue was removed with
animals that were mated with C57Bl/6 females. Germline transmis- Maceration Solution (Polysciences, Inc) at 508C for 72 hr. Photo-
sion was demonstrated by genomic Southern blot analysis to detect graphs were obtained digitally and processed with Photoshop
the rearranged Tbx1 locus. F1 heterozygotes were used in the software.
analysis.
Analysis of Thyroid and Parathyroid Glands
Screening of the BAC Library Mice were sacrificed at E18.5. The thyroid gland (with associated
High-density gridded membranes containing a BAC library (RPCI 11, parathyroids) of each animal was completely resected with associ-
170 kb average insert size, 253 fold redundant; http://www.chori. ated trachea, fixed and embedded in paraffin. Paraffin blocks were
org/bacpac) were screened with 32P-labeled (random primed DNA completely sectioned at 4–5 mm. At most, only a few sections were
labeling Kit, Boehringer Mannheim Corp.) PCR products correspond
lost during cutting on the microtome. Sections were stained with
to six different loci within the distal half of the 1.5 Mb region deleted
hematoxylin and eosin, and examined at 203 magnification for the
in VCFS/DGS patients. The positive clones were isolated and DNA
presence of easily identified parathyroid glands anywhere within
was prepared (Qiagen Corp.). The ends of the identified clones were
the thyroid sections. One hundred to 125 sections were examined
sequenced using ABI377 automated sequencing machines. Each
for each animal.
sequence was compared to those in GenBank (http://www.
ncbi.nlm.nih.gov/BLAST/) to determine the exact size and location
Immunofluorescence Staining and Flow Cytometric Analysisof the BACs in the genomic sequence of chromosome 22.
Thymocytes (1 3 106) were rinsed with flow cytometry buffer (HANKS
solution containing 0.1% bovine serum albumin and 0.1% sodiumPurification of BAC DNA and Generation of Transgenic Mice
azide), pelleted by centrifuge, and doubly stained with phycoer-BAC DNA was isolated using an alkaline lysis and cesium chloride
ythrin(PE)-labeled anti-CD4 mAb (PharMingen, San Diego, CA) andgradient ultracentrifugation protocol. Rnase-treated DNA was fur-
FITC-conjugated anti-CD8 mAb (PharMingen) on ice for 20 min.ther purified using the Endo-free Plasmid Maxi Kit (Gibco, BRL). Trans-
Cells were then washed twice with staining flow cytometry buffer.fer into injection buffer was achieved by passing the DNA over a
Cells were singly stained with FITC-conjugated anti-CD3 epsilonSepharose CL4b-column (Pharmacia) that was equilibrated with injec-
chain mAb (PharMingen). After washing, cells were fixed with 2%tion buffer (10 mM Tris HCl, pH 7.5; 0.1 mM EDTA; 100 mM NaCl).
paraformaldehyde in PBS. Stained cells were analyzed on EpicsCircular BAC DNA was injected into the pronucleus of fertilized
flow cytometer (Coulter, Miami, FL).FVB zygotes at a concentration of 3 ng/ml. The Transgenics and
Gene Targeting Facility of the Albert Einstein College of Medicine
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